COMPANY NEWS IN BRIEF
J&J reports promising Ebola vaccine dataJohnson & Johnson (J&J) said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data
...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 12:00.
Comments
Namibian Sun
No comments have been left on this article